LexDanaLexDanabeta
Inventor

DAVID Y. JACKSON

Inventor
US

Overview

4→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes44%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides22%
PatentTitleYear
11,932,695Modified antibodies and related compounds, compositions and methods of use202411,547,761Antibody adjuvant conjugates202311,400,164Immunoconjugates targeting HER2202211,229,711Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to BOLT BIOTHERAPEUTICS INC (2)· patent assignee history
2022–2023Patents assigned to UNIV LELAND STANFORD JUNIOR (2)· patent assignee history
2022Patents assigned to MAGENTA THERAPEUTICS INC (1)· patent assignee history
2022–2024Based in US· patent location history
2024Patents assigned to SENSEI BIOTHERAPEUTICS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BOLT BIOTHERAPEUTICS INC22022–2023
UNIV LELAND STANFORD JUNIOR22022–2023
MAGENTA THERAPEUTICS INC12022
SENSEI BIOTHERAPEUTICS INC12024
Locations
LocationPatentsSpan
US42022–2024